Reaching Diverse Patient Populations With Personalized Treatment Methods

Strategies for ensuring that innovation with PROs remains parallel with advancements in disease detection and progression.

In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.

Examining the implications of the recent US executive orders concerning diversity, equity, and inclusion pursuits—and the key questions each clinical trial stakeholder must now navigate.

In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.

The clinical trial industry has a rare opportunity to redefine its role in public health conversations.

Research collaboration between Tufts and the Society for Clinical Research Sites explores the prevalence of this belief in healthcare.